The Utility of Prostate-Specific Membrane Antigen-11 PET in Detection and Management of Central Nervous System Neoplasms-Reference-Cited by-同舟云学术

The Utility of Prostate-Specific Membrane Antigen-11 PET in Detection and Management of Central Nervous System Neoplasms

Published:2024-04-05 Issue:7 Volume:49 Page:e340-e345
ISSN:1536-0229
Container-title:Clinical Nuclear Medicine
language:en
Short-container-title:Clin Nucl Med

Author:

Dawod Mina¹,Rush Evan²,Nagib Paul B.¹,Aduwo Jessica¹,Bodempudi Pranav³,Appiah-Kubi Emmanuel²

Affiliation:

1. The Ohio State University College of Medicine

2. Department of Radiology, The Ohio State University College of Medicine

3. The Ohio State University, Columbus, OH.

Abstract

Abstract We present a case series of 5 patients diagnosed with schwannoma and 1 patient diagnosed with astrocytoma who underwent PSMA PET imaging for tumor detection. We retrospectively analyzed the records of 4 male and 2 female patients (mean age, 53.2 ± 13.2) who underwent PSMA PET imaging between March and September 2023. PET interpretation showed increased Ga-PSMA-11 accumulation in all patients with a mean SUVmax of 3.11 ± 1.8. This series underscores PSMA PET’s potential for CNS neoplasm detection.

Publisher

Ovid Technologies (Wolters Kluwer Health)

Reference36 articles.

1. Potential of radiolabeled PSMA PET/CT or PET/MRI diagnostic procedures in gliomas/glioblastomas;Curr Radiopharm,2020

2. How clinical imaging can assess cancer biology;Insights Imaging,2019

3. Molecular imaging using PSMA PET/CT versus multiparametric MRI for initial staging of prostate cancer: comparing apples with oranges?;Eur J Nucl Med Mol Imaging,2016

4. Guiding management of therapy in prostate cancer: time to switch from conventional imaging to PSMA PET?;Ther Adv Med Oncol,2019

5. Clinical applications of PET/MRI: current status and future perspectives;Diagn Interv Radiol,2014